Update on interventional cardiology 2013;Actualización en cardiología intervencionista 2013

Revista Espanola de Cardiologia

Volumn 67, Issue 4, 2014, Pages 305-311

  Hernández Hernández, Felipe ^a   Rumoroso Cuevas, José Ramón ^b   García Del Blanco, Bruno ^c   Trillo Nouche, Ramiro ^d  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d University Hospital of Santiago de Compostela   (Spain)

Author keywords

Drug eluting stent; Fractional flow reserve; Intravascular ultrasound; Non ST segment elevation myocardial infarction; Percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

POLYMER; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANGIOPLASTY; AORTA PROSTHESIS; ARTICLE; CARDIOLOGY; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; HEART ATRIUM APPENDAGE; HEART FORAMEN OVALE; HEART MUSCLE REVASCULARIZATION; INTERVENTION STUDY; KIDNEY DENERVATION; LEFT CORONARY ARTERY; MEDICAL LITERATURE; MEDICAL RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PUBLICATION; RESTENOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOSIS; HUMAN; MYOCARDIAL INFARCTION; STENT;

ANTICOAGULANTS; DIAGNOSTIC IMAGING; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; STENTS;

EID: 84937965733     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2013.10.028     Document Type: Article

References (48)

1. P. Avanzas, A. Bayes-Genis, L. Pérez de Isla, J. Sanchis, and M. Heras Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Los Angeles, California, Estados Unidos, 3-7 de noviembre de 2012) Rev Esp Cardiol 66 2013 55.e1 55.e11
2. P. Avanzas, A. Bayes-Genis, L. Pérez de Isla, J. Sanchis, and M. Heras Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (San Francisco, California, Estados Unidos, 8-12 de marzo de 2013) Rev Esp Cardiol 66 2013 482.e1 482.e8
3. P.W. Armstrong, A.H. Gershlick, P. Goldstein, R. Wilcox, T. Danays, Y. Lambert STREAM Investigative Team Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction N Engl J Med 368 2013 1379 1387
4. O. Fröbert, B. Lagerqvist, G.K. Olivecrona, E. Omerovic, T. Gudnason, and M. Maeng et al. Thrombus aspiration during ST-segment elevation myocardial infarction N Engl J Med 369 2013 1587 1597
5. D.S. Wald, J.K. Morris, N.J. Wald, A.J. Chase, R.J. Edwards, and L.O. Hughes et al. Randomized trial of preventive angioplasty in myocardial infarction N Engl J Med 369 2013 1115 1123
6. B. Ibáñez, V. Fuster, C. Macaya, J. Jiménez- Borreguero, A. Iñiguez, and A. Fernández-Ortiz et al. Modulación del sistema betaadrenérgico durante el infarto agudo de miocardio: justificación para un nuevo ensayo clínico Rev Esp Cardiol 64 Supl 2 2011 28 33
7. B. Ibanez, C. Macaya, V. Sánchez-Brunete, G. Pizarro, L. Fernández-Friera, and A. Mateos et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial Circulation 128 2013 1495 1503
8. D.S. Menees, E.D. Peterson, Y. Wang, J.P. Curtis, J.C. Messenger, and J.S. Rumsfeld et al. Door-to-balloon time and mortality among patients undergoing primary PCI N Engl J Med 369 2013 901 909
9. H. Thiele, U. Zeymer, F.J. Neumann, M. Ferenc, H.G. Olbrich, and J. Hausleiter et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomized, open-label trial Lancet 382 2013 1638 1645
10. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) P.G. Steg, S.K. James, D. Atar, L.P. Badano, C.B. Lundqvist, and M.A. Borger et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
11. P.G. Steg, S.R. Mehta, C.V. Pollack Jr., C. Bode, M. Cohen, W.J. French TAO Investigators Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial JAMA 310 2013 1145 1155
12. G. Montalescot, L. Bolognese, D. Dudek, P. Goldstein, C. Hamm, and J.F. Tanguay et al. Pretreatment with prasugrel in non - ST-segment elevation acute coronary syndromes N Engl J Med 369 2013 999 1010
13. M.E. Farkouh, M. Domanski, L.A. Sleeper, F.S. Siami, G. Dangas, and M. Mack et al. Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
14. E.A. Magnuson, M.E. Farkouh, V. Fuster, K. Wang, K. Vilain, and H. Li et al. Cost-effectiveness of PCI with drug eluting stents versus bypass surgery for patients with diabetes and multi-vessel coronary artery disease: Results from the FREEDOM trial Circulation 127 2013 820 831
15. J.M. De la Torre Hernandez, A. De Belder, R. Lopez-Palop, D. Hildick-Smith, F. Hernandez, and P. O'Kane et al. Everolimus-eluting vs. bare metal stent in octogenarians: the XIMA trial. Results at one-year follow-up EuroPCR 2013 París, 21-24 May 2013
16. M. Hamon, C. Pristipino, C. Di Mario, J. Nolan, J. Ludwig, and M. Tubaro et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care and Thrombosis of the European Society of Cardiology EuroIntervention 8 2013 1242 1251
17. J.M. De la Torre Hernandez, F. Alfonso, A. Sanchez Recalde, M.F. Jimenez Navarro, A. Perez de Prado, and F. Hernandez et al. Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry) Am J Cardiol 111 2013 676 683
18. S.L. Chen, B. Xu, Y.L. Han, I. Sheiban, J.J. Zhang, and F. Ye et al. Comparison of double kissing crush versus culotte stenting for unprotected distal left main bifurcation lesions. Results from a multicenter, randomized, prospective DKCRUSH-III study J Am Coll Cardiol 61 2013 1482 1488
19. T. Schwalm, J. Carlsson, A. Meissner, B. Lagerqvist, and S. James Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) EuroIntervention 9 2013 564 572
20. A.R. De Caterina, F. Cuculi, and A.P. Banning Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents EuroIntervention 8 2013 1326 1334
21. R. Moreno, E. García, R. Teles, J.R. Rumoroso, H. Cyrne Carvalho, F.J. Goicolea CIBELES Investigators Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial Circ Cardiovasc Interv 6 2013 21 28
22. M. Natsuaki, K. Kozuma, T. Morimoto, K. Kadota, T. Muramatsu, Y. Nakagawa NEXT Investigators Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial J Am Coll Cardiol 62 2013 181 190
23. S. Windecker Safety and clinical performance of the drug-eluting Orsiro stent in the treatment of subjects with single de novo coronary artery lesions (BIOFLOW-II) EuroPCR 2013 París, 21-24 May 2013
24. T. Gori, E. Schulz, U. Hink, P. Wenzel, F. Post, A. Jabs, and T. Münzel Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes EuroIntervention 9 2013 1036 1041
25. C. Simsek, M. Magro, Y. Onuma, E. Boersma, P. Smits, and C. Dorange et al. Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH) EuroIntervention 2013 pii: 20121019-03
26. P. Widimsky, V. Kocka, L. Lisa, T. Budesinsky, and P. Tousek Bioabsorbable vascular scaffolds in acute STEMI (PRAGUE-19 study) EuroPCR 2013 París, 21-24 May 2013
27. J.P. Collet, T. Cuisset, G. Rangé, G. Cayla, S. Elhadad, C. Pouillot ARCTIC Investigators Bedside monitoring to adjust antiplatelet therapy for coronary stenting N Engl J Med 367 2012 2100 2109
28. P.A. Gurbel, D. Erlinge, E.M. Ohman, B. Neely, M. Neely, and S.G. Goodman et al. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS Platelet Function Substudy JAMA 308 2012 1785 1794
29. D.L. Bhatt, G.W. Stone, K.W. Mahaffey, C.M. Gibson, P.G. Steg, C.W. Hamm CHAMPION PHOENIX Investigators Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med 368 2013 1303 1313
30. R. Mehran, U. Baber, P.G. Steg, C. Ariti, G. Weisz, and B. Witzenbichler et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study Lancet 382 2013 1714 1722
31. O. Angeras, S. Koul, M. Soderbom, P. Albertsson, T. Ramunddal, and G. Matejka et al. Heparin versus bivalirudin in patients with NSTE-ACS undergoing PCI - A report from the Swedish coronary angiography and angioplasty registry (SCAAR) EuroPCR 2013 París, 21-24 May 2013
32. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, and B. Cercek et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
33. R. Waksman, J. Legutko, J. Singh, Q. Orlando, S. Marso, and T. Schloss et al. FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study J Am Coll Cardiol 61 2013 917 923
34. G. Toth, B. De Bruyne, F. Casselman, F. De Vroey, S. Pyxaras, and L. Di Serafino et al. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery Circulation 128 2013 1405 1411
35. J.M. De la Torre Hernández, J.A. Baz Alonso, J.A. Gómez Hospital, F. Alfonso, T. Garcia Camarero, and F. Gimeno de Carlos et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at patient level of 4 registries J Am Coll Cardiol 62 18 Suppl 1 2013 B9
36. L.G. Svensson, M. Tuzcu, S. Kapadia, E.H. Blackstone, E.E. Roselli, and A.M. Gillinov et al. A comprehensive review of the PARTNER trial J Thorac Cardiovasc Surg 145 3 Suppl 2013 S11 S16
37. S. Windecker One-year outcomes from the SOURCE XT post-approval study EuroPCR 2013 París, 21-24 May 2013
38. ® en pacientes con estenosis aórtica grave y aorta de porcelana: seguimiento a medio plazo Rev Esp Cardiol 66 2013 775 781
39. N.M. Van Mieghem, and R.M.A. Van der Boon Aorta de porcelana y estenosis aórtica grave: ¿la implantación percutánea de válvula aórtica es el nuevo tratamiento estándar? Rev Esp Cardiol 66 2013 765 767
40. J.D. Carroll, J.L. Saver, D.E. Thaler, R.W. Smalling, S. Berry, L.A. MacDonald RESPECT Investigators Closure of patent foramen ovale versus medical therapy after cryptogenic stroke N Engl J Med 34 2013 3362 3369
41. M. Hornung, S.C. Bertog, J. Franke, D. Id, M. Taaffe, and N. Wunderlich et al. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale Eur Heart J 2013 [Epub ahead of print]
42. V.Y. Reddy, S.K. Doshi, H. Sievert, M. Buchbinder, P. Neuzil, K. Huber PROTECT AF Investigators Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial Circulation 127 2013 720 729
43. L. Mauri, E. Foster, D.D. Glower, P. Apruzzese, J.M. Massaro, H.C. Herrmann EVEREST II Investigators 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation J Am Coll Cardiol 62 2013 317 328
44. M.D. Esler, H. Krum, M. Schlaich, R.E. Schmieder, M. Böhm, P.A. Sobotka Symplicity HTN-2 Investigators Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial Circulation 126 2012 2976 2982
45. M. Böhm, F. Mahfoud, C. Ukena, A. Bauer, E. Fleck, and U.C. Hoppe et al. Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry EuroIntervention 9 2013 484 492
46. M.P. Schlaich, R.E. Schmieder, G. Bakris, P.J. Blankestijn, M. Böhm, and V.M. Campese et al. International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension J Am Coll Cardiol 62 2013 2031 2045
47. S.G. Worthley, C.P. Tsioufis, M.I. Worthley, A. Sinhal, D.P. Chew, and I.T. Meredith et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial Eur Heart J 34 2013 2132 2140
48. R. Delewi, A. Hirsch, J.G. Tijssen, V. Schächinger, W. Wojakowski, and J. Roncalli et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis Eur Heart J 2013 10.1093/eurheartj/ eht372